These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 18785508

  • 21. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP).
    Alasfoor K, Alrasheed M, Alsayegh F, Mousa SA.
    Ann Hematol; 2009 Mar; 88(3):239-43. PubMed ID: 18704420
    [Abstract] [Full Text] [Related]

  • 22. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [Abstract] [Full Text] [Related]

  • 23. [Efficacy of lower dose rituximab therapy for idiopathic thrombocytopenic purpura.].
    Sui T, Xue F, Zhao HF, Ge J, Zhou H, Zhang L, Bai J, Yang RC.
    Zhonghua Xue Ye Xue Za Zhi; 2010 Mar; 31(3):161-3. PubMed ID: 20510104
    [Abstract] [Full Text] [Related]

  • 24. Successful use of rituximab in refractory idiopathic thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Al-Ahmad M, Al-Rasheed M, Al-Muhani A.
    J Investig Allergol Clin Immunol; 2010 Mar; 20(3):259-62. PubMed ID: 20635793
    [Abstract] [Full Text] [Related]

  • 25. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M.
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [Abstract] [Full Text] [Related]

  • 26. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
    Thude H, Gruhn B, Werner U, Schorner U, Häfer R, Zintl F, Barz D.
    Acta Haematol; 2004 May; 111(4):221-4. PubMed ID: 15153715
    [Abstract] [Full Text] [Related]

  • 27. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
    Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB.
    Br J Haematol; 2012 Aug; 158(4):539-47. PubMed ID: 22775462
    [Abstract] [Full Text] [Related]

  • 28. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A.
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [Abstract] [Full Text] [Related]

  • 29. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
    Kuwana M, Iki S, Urabe A.
    Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
    [Abstract] [Full Text] [Related]

  • 30. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
    Zaja F, Volpetti S, Chiozzotto M, Puglisi S, Isola M, Buttignol S, Fanin R.
    Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
    [Abstract] [Full Text] [Related]

  • 31. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR, Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP.
    Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
    [Abstract] [Full Text] [Related]

  • 32. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
    Najaoui A, Bakchoul T, Stoy J, Bein G, Rummel MJ, Santoso S, Sachs UJ.
    Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
    [Abstract] [Full Text] [Related]

  • 33. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
    Zhou Z, Yang R.
    Crit Rev Oncol Hematol; 2008 Jan; 65(1):21-31. PubMed ID: 17681784
    [Abstract] [Full Text] [Related]

  • 34. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
    Riksen NP, Keuning JJ, Vreugdenhil G.
    Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
    [Abstract] [Full Text] [Related]

  • 35. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, Sarmiento E, Micheloud D, Fernandez-Cruz E.
    Ann N Y Acad Sci; 2005 Jun; 1051():666-71. PubMed ID: 16127007
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of standard dose rituximab for refractory idiopathic thrombocytopenic purpura in children.
    Dai WJ, Zhang RR, Yang XC, Yuan YF.
    Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2379-83. PubMed ID: 26214772
    [Abstract] [Full Text] [Related]

  • 37. Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia.
    Pusiol A, Cesaro S, Nocerino A, Picco G, Zanesco L, Bisogno G.
    Eur J Pediatr; 2004 Jun; 163(6):305-7. PubMed ID: 15346911
    [Abstract] [Full Text] [Related]

  • 38. Low-dose rituximab in adult patients with primary immune thrombocytopenia.
    Zaja F, Vianelli N, Volpetti S, Battista ML, Defina M, Palmieri S, Bocchia M, Medeot M, De Luca S, Ferrara F, Isola M, Baccarani M, Fanin R.
    Eur J Haematol; 2010 Oct; 85(4):329-34. PubMed ID: 20546023
    [Abstract] [Full Text] [Related]

  • 39. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.
    Giagounidis AA, Anhuf J, Schneider P, Germing U, Söhngen D, Quabeck K, Aul C.
    Eur J Haematol; 2002 Aug; 69(2):95-100. PubMed ID: 12366712
    [Abstract] [Full Text] [Related]

  • 40. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX, Hou M, Zhu YY, Peng J, Ji XB, Zhang F, Wang L.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 28; 85(49):3464-8. PubMed ID: 16686061
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.